Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc.
ALLO
Valuace
70
Růst
30
Zdraví
75
Cena
$ 1.19
Dnes
+0.02 (1.24%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.3B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-67%
ROA
-48%
PE
-2
PS
0
Cena 1R
1-4
⌀ Cena
1.29
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
12-03-2026
Poslední dividenda

Profil

Společnost Allogene Therapeutics, Inc., která působí v klinickém stádiu imunoonkologie, vyvíjí a komercializuje geneticky navržené allogenní T-buněčné terapie pro léčbu rakoviny. Vyvíjí, vyrábí a komercializuje UCART19, allogenní kandidát na produkt T-buněk chimerického antigenního receptoru (CAR) pro léčbu pediatrických a dospělých pacientů s pozitivní B-buněčnou ALL R/R CD19. Společnost také vyvíjí ALLO-501, anti-CD19 allogenní CAR T lymfom, který je ve fázi I klinické studie pro léčbu R/R non-Hodgkinova lymfomu, a ALLO-501A, který je ve fázi I/II klinické studie pro léčbu R/R velkobuněčného B lymfomu nebo transformovaného folikulárního lymfomu. Kromě toho vyvíjí ALLO-715, allogenní kandidát na přípravek CAR T cell, který je ve fázi I klinické studie pro léčbu R/R mnohočetného myelomu; ALLO-605, alogenní kandidát na přípravek CAR T cell pro léčbu mnohočetného myelomu; ALLO-647, monoklonální protilátka proti CD52; CD70 pro léčbu rakoviny ledvin; ALLO-819, allogenní kandidát na přípravek CAR T cell pro léčbu akutní myeloidní leukémie; a DLL 3 k léčbě malobuněčného karcinomu plic a jiných agresivních neuroendokrinních nádorů. Společnost má licenční smlouvy a smlouvy o spolupráci se společnostmi Pfizer Inc., Servier, Cellectis S.A. a Notch Therapeutics Inc., jakož i smlouvu o spolupráci v klinických studiích se společností SpringWorks Therapeutics, Inc. Má také smlouvu o strategické spolupráci s Centrem pro preklinické a klinické testování alogenních kandidátů na přípravky z T buněk CAR Texaské univerzity. Společnost byla založena v roce 2017 a sídlí v jižním San Francisku v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
226
Založení
2018-10-11
Adresa
210 East Grand Avenue
CEO
David D. Chang

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 20252024202320222021202020192018
Total Revenues0.000.0022.0095.00243.0038,489.000.000.000.00
Cost of Revenues37,320.0012,359.000.00242,914.000.000.000.000.000.00
Gross Profit-37,320.00-12,359.0022.00-242,819.00243.0038,489.000.000.000.00
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues0.000.000.000.000.000.000.0022.0021.0043.00
Cost of Revenues3,057.0031,164.000.003,099.003,233.000.000.003,555.0054,661.003,572.00
Gross Profit-3,057.00-31,164.000.00-3,099.00-3,233.000.000.00-3,533.00-54,640.00-3,529.00
Operating Income TTM 20252024202320222021202020192018
R&D Expenses0.000.000.00242,914.00256,387.00220,176.00192,987.00144,535.00151,860.00
Selling General & Admin Expenses0.000.000.0071,673.0079,305.0074,105.0065,256.0057,473.0040,982.00
Depreciation & Amortization12,359.0012,359.0013,639.0014,199.0014,295.0010,454.007,586.0017,083.001,500.00
Total Operating Expenses171,995.00194,574.00273,221.00327,832.00335,692.00294,281.00258,243.00202,008.00192,842.00
Operating Income-209,315.00-206,933.00-273,199.00-327,737.00-335,449.00-255,792.00-258,243.00-202,008.00-192,842.00
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.0054,661.0045,977.00
Selling General & Admin Expenses0.000.000.000.000.000.000.000.0017,224.0017,041.00
Depreciation & Amortization3,057.003,097.003,106.003,099.003,233.003,207.003,644.003,555.003,477.003,572.00
Total Operating Expenses39,347.0013,737.0056,819.0062,092.0057,257.0071,774.0071,431.0065,971.0071,885.0063,018.00
Operating Income-42,404.00-44,901.00-56,819.00-65,191.00-60,490.00-71,774.00-71,431.00-69,504.00-71,864.00-62,975.00
Net Income TTM 20252024202320222021202020192018
Interest Income15,363.0019,289.0020,153.0018,307.004,566.001,714.009,164.0017,351.005,789.00
Interest Expense1,075.001,075.00181.000.00-17,112.000.000.000.003,358.00
Other Expense18,429.0016,047.0016,052.00472.002,817.00-1,213.008,022.0017,083.00-21,211.00
IBT-190,886.00-190,886.00-257,147.00-327,265.00-332,632.00-257,005.00-250,221.00-184,925.00-211,622.00
Income Tax Expense0.000.00443.000.00-2,817.00-12,168.00-16,750.00-331.00-117.00
Net Income-190,886.00-190,886.00-257,590.00-327,265.00-329,815.00-244,837.00-233,471.00-184,594.00-211,505.00
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income3,660.000.006,187.005,516.003,027.006,705.004,988.005,433.006,265.006,205.00
Interest Expense313.00344.00268.00150.0081.00100.000.000.00366.000.00
Other Expense3,594.003,501.005,876.005,458.00994.005,481.005,073.004,504.00-4,083.001,660.00
IBT-38,810.00-41,400.00-50,943.00-59,733.00-59,496.00-66,293.00-66,358.00-65,000.00-85,778.00-61,315.00
Income Tax Expense0.000.000.000.00443.000.000.000.00-65.00-6,205.00
Net Income-38,810.00-41,400.00-50,943.00-59,733.00-59,939.00-66,293.00-66,358.00-65,000.00-85,778.00-61,315.00
Per Share Data TTM 20252024202320222021202020192018
EPS$0.00$0.00$0.00$-2.09$-2.30$-1.80$-1.94$-1.83$-7.31
EPS Diluted$0.00$0.00$0.00$-2.09$-2.30$-1.80$-1.94$-1.83$-7.31
Shares Outstanding220,622.67220,622.67194,812.00156,931.78143,147.17135,820.39120,370.18101,061.1528,948.39
Diluted Shares Outstanding220,622.67220,622.67194,812.00156,931.78143,147.17135,820.39120,370.18101,061.1528,948.39
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.51$-0.37
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.51$-0.37
Shares Outstanding220,622.67222,038.68218,929.55215,359.00210,572.00209,189.00190,027.00169,128.00168,335.83167,649.01
Diluted Shares Outstanding220,622.67222,038.68218,929.55215,359.00210,572.00209,189.00190,027.00169,128.00168,335.83167,649.01
Current Assets TTM 20242023202220212020201920182017
Cash And Equivalents170,667.0075,218.0083,155.00576,471.00809,481.001,032,118.00588,855.00721,350.000.00
Short Term Investments273,961.00217,258.00365,542.00455,416.00283,988.00644,559.00355,407.00366,952.000.00
Total Cash & ST Investments444,628.00292,476.00448,697.00576,471.00809,481.001,032,118.00588,855.00721,350.000.00
Accounts Receivable2,000.001,900.000.000.000.000.002,403.003,108.000.00
Inventory0.000.000.000.000.000.00-60,725.00-261,966.000.00
Other Current Assets10,496.009,010.0010,418.0011,504.0014,021.0017,220.0014,043.005,490.000.00
Total Current Assets457,124.00303,386.00459,115.00528,824.00809,481.00845,130.00544,576.00467,982.000.00
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents37,815.0052,332.0042,455.0075,218.0051,239.00170,667.0051,039.0083,155.0069,246.00154,758.00
Short Term Investments214,379.00220,788.00237,588.00217,258.00240,325.00273,961.00333,821.00365,542.00396,259.00337,204.00
Total Cash & ST Investments252,194.00273,120.00280,043.00292,476.00291,564.00444,628.00384,860.00448,697.00465,505.00491,962.00
Accounts Receivable2,100.000.000.000.000.002,000.001,700.000.000.000.00
Inventory0.000.000.000.000.000.000.00-1,700.00-1,600.00-1,100.00
Other Current Assets6,425.009,535.0011,533.0010,910.0012,851.0010,496.008,804.0010,418.007,949.0010,139.00
Total Current Assets260,719.00282,655.00291,576.00303,386.00304,415.00457,124.00395,364.00459,115.00473,454.00502,101.00
Long-Term Assets TTM 20242023202220212020201920182017
Net Property, Plant & Equipment150,465.00131,261.00163,181.00196,431.00181,020.00160,135.00100,944.0041,610.000.00
Goodwill0.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.00151.00754.000.00
Long-Term Investments11,426.0080,673.003,645.0059,151.00370,184.00207,946.0063,214.00261,966.000.00
Other Long-Term Assets27,868.0033,390.0016,896.0032,673.00-322,051.0014,618.008,917.001,543.000.00
Total Long-Term Assets189,759.00245,324.00183,722.00288,255.00229,153.00382,699.00173,226.00305,873.000.00
Total Assets646,883.00548,710.00642,837.00817,079.001,038,634.001,227,829.00717,802.00773,855.000.00
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment116,831.00120,824.00127,067.00131,261.00135,302.00150,465.00160,414.00163,181.00181,469.00186,700.00
Goodwill0.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.000.00
Long-Term Investments35,236.0029,510.0055,506.0080,673.00111,821.0011,426.0025,413.003,645.0037,535.0062,496.00
Other Long-Term Assets26,985.0037,604.0033,833.0033,390.0037,582.0027,868.005,159.0016,896.0019,868.0019,674.00
Total Long-Term Assets179,052.00187,938.00216,406.00245,324.00284,705.00189,759.00190,986.00183,722.00238,872.00268,870.00
Total Assets439,771.00470,593.00507,982.00548,710.00589,120.00646,883.00586,350.00642,837.00712,326.00770,971.00
Current Liabilities TTM 20242023202220212020201920182017
Accounts Payable12,936.005,394.005,897.0013,890.0010,255.0010,390.009,250.0012,338.000.00
Short-Term Debt7,221.007,509.006,775.006,002.000.002,974.000.000.000.00
Other Current Liabilities17,148.0022,620.0024,321.0033,741.0037,496.0041,964.0023,829.0017,121.002.00
Current Liabilities37,305.0035,523.0037,079.0054,518.0048,174.0094,320.0033,079.0029,459.002.00
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable3,699.004,851.005,058.005,394.005,506.0012,936.005,779.005,897.006,205.0010,229.00
Short-Term Debt8,008.000.000.007,509.000.007,221.006,930.006,775.006,578.000.00
Other Current Liabilities20,126.0026,824.0024,964.0022,620.0027,065.0017,148.0018,099.0024,321.0024,617.0044,263.00
Current Liabilities31,833.0031,675.0030,022.0035,523.0032,571.0037,305.0030,894.0037,079.0037,636.0054,721.00
Long-Term Liabilities TTM 20242023202220212020201920182017
Long-Term Debt86,989.0083,247.0088,346.0095,122.0069,929.0050,809.0051,349.0034,456.000.00
Capital Leases86,989.0090,756.0095,121.0095,122.0069,929.0053,783.0051,349.0034,456.000.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.00
Total Liabilities131,845.00126,531.00130,604.00151,209.00122,228.00148,212.0088,779.0070,691.002.00
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt77,134.0079,241.0081,292.0083,247.0085,135.0086,989.0088,916.0088,346.0090,102.0091,821.00
Capital Leases0.0079,241.0081,292.0090,756.0085,135.0086,989.0088,916.0095,121.0090,102.0091,821.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.00
Total Liabilities124,442.00126,032.00122,589.00126,531.00125,372.00131,845.00124,983.00130,604.00129,224.00148,065.00
Total Common Equity TTM 20242023202220212020201920182017
Common Stock209.00212.00169.00144.00142.00140.00124.00121.0026.00
Retained Earnings-1,693,591.00-1,819,823.00-1,562,233.00-1,235,980.00-903,348.00-646,343.00-396,122.00-211,528.00-23.00
Comprehensive Income-780.00-89.00-955.00-9,926.00-2,567.00268.001,145.00306.000.00
Total Common Equity515,038.00422,179.00512,233.00665,870.00916,406.001,079,617.00629,023.00703,164.00-2.00
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock223.00220.00219.00212.00210.00209.00170.00169.00168.00167.00
Retained Earnings-1,971,899.00-1,930,499.00-1,879,556.00-1,819,823.00-1,759,884.00-1,693,591.00-1,627,233.00-1,562,233.00-1,473,988.00-1,412,673.00
Comprehensive Income235.00-45.0043.00-89.00157.00-780.00-927.00-955.00-2,411.00-3,851.00
Total Common Equity315,329.00344,561.00385,393.00422,179.00463,748.00515,038.00461,367.00512,233.00583,102.00622,906.00
Other TTM 20242023202220212020201920182017
Total Debt94,210.0090,756.0095,121.0095,122.0069,929.0053,783.0051,349.0034,456.000.00
Book Value515,038.00422,179.00512,233.00665,870.00916,406.001,079,617.00629,023.00703,164.00-2.00
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.000.000.000.000.000.000.000.000.000.00
Book Value315,329.00344,561.00385,393.00422,179.00463,748.00515,038.00461,367.00512,233.00583,102.00622,906.00
Cash Flow From Operating Activities TTM 20252024202320222021202020192018
Net Income-281,930.00-190,886.00-257,590.00-327,265.00-332,632.00-257,005.00-250,221.00-184,594.00-211,505.00
Depreciation & Amortization14,248.0012,359.0013,639.0014,199.0014,295.0010,454.007,586.005,027.001,500.00
Stock-Based Compensation56,070.0037,642.0051,743.0065,951.0083,600.0080,818.0065,261.0046,063.0018,566.00
Change Working Capital-39,481.00-10,877.00-24,799.00-15,305.003,706.00-32,089.0053,922.00-6,878.0012,096.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.000.00
Change In Accounts Payable2,421.00-1,231.00-503.00-7,502.004,868.00-767.00615.00-985.008,800.00
Change In Inventories0.000.000.000.000.000.000.000.000.00
Other Non-cash Items33,793.002,516.0016,264.0024,687.002,433.002,611.003,955.003,363.00134,807.00
Cash from Operations-228,724.000.000.00-237,733.00-220,519.00-184,812.00-115,093.00-137,350.00-44,653.00
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-38,810.00-41,400.00-50,943.00-59,733.00-59,939.00-66,293.00-66,358.00-65,000.00-89,257.00-61,315.00
Depreciation & Amortization3,057.003,097.003,106.003,099.003,233.003,207.003,644.003,555.003,477.003,572.00
Stock-Based Compensation8,130.008,652.008,685.0012,175.0012,873.0013,387.0013,559.0011,924.0015,233.0015,354.00
Change Working Capital-202.00-145.00-2,236.00-8,294.005,270.0021,191.00-16,750.00-4,441.00-3,401.00-14,889.00
Change In Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Change In Accounts Payable599.00-1,072.00-422.00-336.0034.00-7,227.006,808.00-118.00-302.00-3,967.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.00
Other Non-cash Items226.00108.002,358.00-176.001,865.00-15,607.002,317.00-1,937.0075.00147.00
Cash from Operations0.000.000.000.000.000.000.000.00-53,707.00-55,530.00
Cash Flow From Investing Activities TTM 20252024202320222021202020192018
Capital Expenditure-201.00-386.00-694.00-1,516.00-5,191.00-21,446.00-65,958.00-50,791.00-3,234.00
Acquisitions-33,387.000.000.000.000.00-17,710.000.00-5,075.000.00
Investments-391,854.00-138,257.00-361,475.00-438,629.00-248,109.00-525,583.00-1,037,591.00-252,628.00-649,307.00
Sales of Investment521,995.00234,202.00437,857.00603,434.00359,459.00728,394.00598,426.00472,578.0021,841.00
Other Investing Activities130,141.000.000.000.000.000.000.000.00-2,098.00
Cash from Investing129,940.000.000.00163,289.00106,159.00163,655.00-505,123.00164,084.00-632,798.00
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure0.00-243.00-44.00-99.00-257.00-429.000.00-8.00-181.00-12.00
Acquisitions0.000.000.000.000.000.000.000.00-67,642.0034,255.00
Investments-28,377.00-49,734.00-9,921.00-50,225.00-46,974.00-190,762.00-42,608.00-81,131.00-68,702.00-199,413.00
Sales of Investment61,990.0061,912.0053,800.0056,500.00102,165.00115,199.00117,221.00103,272.00136,344.00165,158.00
Other Investing Activities0.000.000.000.000.000.000.000.0067,642.00-34,255.00
Cash from Investing0.000.000.000.000.000.000.000.0067,461.00-34,267.00
Cash Flow From Financing Activities TTM 20252024202320222021202020192018
Debt Repaid0.000.000.000.000.000.000.000.000.00
Debt Issued2,389.0090,756.00-4,365.00-1.0025,193.0016,146.002,434.0016,893.0034,456.00
Issuance of Common Stock108,921.000.000.0091,112.00489.000.00621,933.0054,219.00343,689.00
Repurchase of Common Stock1,621.000.000.000.002,461.003,617.002,843.001,783.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.00
Other Financing Activities8,370.000.000.004,583.000.008,346.008,815.002,958.00427,493.00
Cash from Financing114,693.000.000.0095,695.002,950.0011,963.00633,591.0058,960.00771,182.00
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.000.000.00
Debt Issued85,142.005,901.00-2,051.00-9,464.005,621.00-9,075.00-1,636.00725.005,019.00-1,719.00
Issuance of Common Stock0.000.000.000.000.000.000.000.00-3,337.003,194.00
Repurchase of Common Stock0.000.000.000.000.000.000.000.00765.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.00155.001,091.00
Cash from Financing0.000.000.000.000.000.000.000.00155.004,285.00
Cash position TTM 20252024202320222021202020192018
Net Change in Cash5,617.00-23,530.00-7,937.0021,251.00-111,410.00-9,194.0013,375.0085,694.0093,731.00
Closing Cash Balance170,667.0061,980.0085,510.0093,447.0072,196.00183,606.00192,800.00179,425.0093,731.00
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash13,873.00-14,517.009,877.00-32,763.0023,979.00-119,428.00119,628.00-32,116.0013,909.00-85,512.00
Closing Cash Balance61,980.0037,815.0062,624.0052,747.0085,510.0061,531.00170,667.0061,331.0093,447.0079,538.00
Free Cash Flow TTM 20252024202320222021202020192018
Free Cash Flow-228,925.00-149,632.00-200,994.00-239,249.00-225,710.00-206,258.00-181,051.00-188,141.00-47,887.00
Real Free Cash Flow-284,995.00-187,274.00-252,737.00-305,200.00-309,310.00-287,076.00-246,312.00-234,204.00-66,453.00
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-27,599.00-29,931.00-39,074.00-53,028.00-36,955.00-44,544.00-63,588.00-55,907.00-53,888.00-55,542.00
Real Free Cash Flow-35,729.00-38,583.00-47,759.00-65,203.00-49,828.00-57,931.00-77,147.00-67,831.00-69,121.00-70,896.00
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-2.4-8.7-1.4
P/S01962.99.4
P/B1.41.75.2
P/FCF-2.4-11.4-1.5
Market cap$0.3$1.8
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets19.4 %9.5 %0 %
Debt to Income-44.6 %-26.1 %0 %
Debt to Free cash flow-45.5 %-332.4 %0 %
Interest expense percentage-0.5 %0.2 %0 %
Current ratio8.2 11.9 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-60.5 %-34.2 %0 %
ROA-43.4 %-32.6 %0 %
CapEx to Revenue0 %648.7 %0 %
RaD to Revenue0 %30416.6 %0 %
ROEM0.0 16193

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin0 %-10188.2 %0 %
Operating margin0 %-39309.2 %0 %
Net margin0 %-42193.1 %0 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding222.0 mil 137.1 mil
Employee count0.2 tis 0.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader